@article{bcd4ea1ae2f0440ca38434f51099b262,
title = "Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration-resistant prostate cancer receiving abiraterone acetate: An evidence-based case report and review of literature",
abstract = "Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration-resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point.",
keywords = "abiraterone, lymphocyte, metastatic Castration-Resistant Prostate Cancer, platelet, platelet to lymphocyte ratio, prostate cancer",
author = "Yausep, {Oliver E.} and Raksheeth Agarwal and Rifqha Aulina and Wijaya, {Anthony E.} and Ilonka Amaia and Moekti, {Addina W.} and Ikhwan Rinaldi and Hamid, {Agus Rizal A.H.}",
note = "Publisher Copyright: {\textcopyright} 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",
year = "2019",
month = jan,
day = "1",
doi = "10.1002/ccr3.2288",
language = "English",
volume = "7",
pages = "1585--1590",
journal = "Clinical Case Reports",
issn = "2050-0904",
publisher = "John Wiley and Sons Ltd",
number = "8",
}
